Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Biton

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Epilepsia|May 23, 2013
Kv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsyDorotheé G A Kasteleijn-Nolst Trenité, Victor Biton, Jacqueline A French, et al.
Epilepsy & Behavior : E&B|June 3, 2017
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trialsVictor Biton, Joanne B Rogin, Gregory Krauss, et al.
Epilepsia|October 11, 2021
Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label studyMichael R Sperling, Bassel Abou-Khalil, Sami Aboumatar, et al.
Epilepsy & Behavior : E&B|April 1, 2018
Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizuresEva Andermann, Victor Biton, Selim R Benbadis, et al.
Epilepsia|October 24, 2025
Pharmacokinetics and tolerability of single-dose Staccato® alprazolam in adolescents with epilepsy, and population pharmacokinetic analysis to support dose selection in adolescentsPavel Klein, Gewalin Aungaroon, Victor Biton, et al.
Epilepsia Open|May 25, 2021
Consistent safety and tolerability of Valtoco<sup>®</sup> (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long-term, open-label, repeat-dose safety studyIan Miller, James W Wheless, Robert E Hogan, et al.
Epilepsia|August 21, 2021
Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsyJames W Wheless, Ian Miller, R Edward Hogan, et al.
Epilepsia|May 4, 2021
Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety studyEric B Segal, Daniel Tarquinio, Ian Miller, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Epilepsia|May 23, 2013
Kv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsyDorotheé G A Kasteleijn-Nolst Trenité, Victor Biton, Jacqueline A French, et al.
Epilepsy & Behavior : E&B|June 3, 2017
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trialsVictor Biton, Joanne B Rogin, Gregory Krauss, et al.
Epilepsia|October 11, 2021
Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label studyMichael R Sperling, Bassel Abou-Khalil, Sami Aboumatar, et al.
Epilepsy & Behavior : E&B|April 1, 2018
Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizuresEva Andermann, Victor Biton, Selim R Benbadis, et al.
Epilepsia|October 24, 2025
Pharmacokinetics and tolerability of single-dose Staccato® alprazolam in adolescents with epilepsy, and population pharmacokinetic analysis to support dose selection in adolescentsPavel Klein, Gewalin Aungaroon, Victor Biton, et al.
Epilepsia Open|May 25, 2021
Consistent safety and tolerability of Valtoco<sup>®</sup> (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long-term, open-label, repeat-dose safety studyIan Miller, James W Wheless, Robert E Hogan, et al.
Epilepsia|August 21, 2021
Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsyJames W Wheless, Ian Miller, R Edward Hogan, et al.
Epilepsia|May 4, 2021
Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety studyEric B Segal, Daniel Tarquinio, Ian Miller, et al.
Pageof 5